Monocyte-Derived Macrophage Ferroptosis Amplifies Cholangitis in Primary Biliary Cholangitis via a Calpain/ACSL4 Axis

Tianfu Liu1, Yichen Huang2, Yizhe Wang3

  • 1Department of Hepatology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou 730030, China.

Biomedicines
|June 26, 2026
PubMed

Insights

Monocyte-derived macrophages (MoMFs) drive inflammation in primary biliary cholangitis (PBC) through ferroptosis. Targeting the calpain/ACSL4 axis offers a potential therapeutic strategy for this liver disease.

Area of Science:

  • Immunology
  • Cell Biology
  • Hepatology

Background:

  • Monocyte-derived macrophages (MoMFs) are key drivers of inflammation in primary biliary cholangitis (PBC).
  • The role of MoMF ferroptosis in amplifying PBC-associated cholangitis was previously unclear.
  • The calpain/ACSL4 axis was investigated as a potential regulator of MoMF ferroptosis.

Purpose of the Study:

  • To define ferroptotic programs in MoMFs within the context of PBC.
  • To evaluate the calpain/ACSL4 axis as a regulatory and therapeutic target in PBC.
  • To investigate the crosstalk between MoMFs and cholangiocytes in PBC pathogenesis.

Main Methods:

  • Analysis of human liver single-cell RNA sequencing data to identify MoMF ferroptosis signatures.
  • Multiplex immunofluorescence to detect ACSL4 and 4-hydroxynonenal (4-HNE) in human PBC tissues.
  • Utilized a 2OA-BSA-induced mouse model of PBC to assess liver injury, inflammation, and ferroptosis markers.
  • Pharmacological intervention with Liproxstatin-1 (Lip-1), rosiglitazone (ROSI), or PD150606 in mouse models and bone marrow-derived macrophages (BMDMs).

Main Results:

  • MoMFs were expanded in PBC livers, exhibiting strong ferroptosis signatures centered on ACSL4 and increased inflammatory crosstalk with cholangiocytes.
  • Human PBC tissues showed elevated ACSL4 and 4-HNE expression in CD11b+CD68+ cells.
  • PBC-like mice displayed increased oxidative stress (MDA, decreased GSH) and macrophage infiltration associated with ferroptosis markers.
  • Treatments with Lip-1, ROSI, or PD150606 ameliorated liver injury, reduced inflammation, and limited macrophage infiltration in PBC models.
  • PBC-derived BMDMs showed upregulated ACSL4 and CAPN1/2, increased sensitivity to ferroptosis inducers, and attenuated ferroptosis upon treatment with Ferrostatin-1 (Fer-1), ROSI, or PD150606.

Conclusions:

  • MoMF ferroptosis is a significant factor in the pathogenesis of primary biliary cholangitis.
  • The calpain/ACSL4 axis represents a pharmacologically tractable target that influences MoMF ferroptotic susceptibility.
  • Targeting this axis holds promise for mitigating macrophage-driven inflammatory liver injury in PBC.

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...